Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income	$ 11,211	$ 14,771
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of capitalized software costs	12,061	10,725
Amortization of debt issuance costs	976	254
Amortization of other intangibles	4,488	4,564
Net amortization (accretion) of premiums/discounts on marketable securities	(1,956)
Change in fair value of contingent consideration	400
Depreciation	2,064	2,646
Excess tax deficiency (benefit) from share-based compensation	170	(434)
Gain on disposition of Commercial Dental assets		(10,296)
Impairment of assets	171	1,329
Realized loss on marketable securities	734
Loss on disposal of equipment and improvements	37	74
Loss on foreign currency exchange rates	100	7
Non-cash operating lease costs	763	1,682
Provision for bad debts	1,826	600
Share-based compensation	17,422	17,453
Changes in assets and liabilities:
Accounts receivable	(2,606)	(1,527)
Contract assets	(972)	(2)
Accounts payable	(1,571)	3,153
Contract liabilities	(23,170)	1,739
Accrued compensation and related benefits	(7,802)	(20,422)
Income taxes	(2,825)	3,934
Deferred compensation	689	(249)
Operating lease liabilities	(1,979)	(4,097)
Other assets and liabilities	(27,746)	7,892
Net cash provided by (used in) operating activities	(17,515)	33,796
Cash flows from investing activities:
Additions to capitalized software costs	(17,420)	(18,416)
Additions to equipment and improvements	(854)	(1,426)
Proceeds from sales of marketable securities	15,457
Proceeds from maturities and redemptions of marketable securities	42,871
Purchases of marketable securities	(63,942)
Proceeds from disposition of Commercial Dental assets		11,253
Net cash used in investing activities	(23,888)	(8,589)
Cash flows from financing activities:
Proceeds from issuance of shares under employee plans	1,430	2,575
Repurchase of common stock		(9,878)
Payments for taxes related to net share settlement of equity awards	(7,104)	(6,124)
Net cash used in financing activities	(5,674)	(13,427)
Effect of exchange rate changes on cash and cash equivalents	(130)	(219)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(47,207)	11,561
Cash, cash equivalents, and restricted cash at beginning of period	105,988	66,747
Cash, cash equivalents, and restricted cash at end of period	58,781	78,308
Supplemental disclosures of cash flow information:
Cash paid for income taxes	6,689	1,963
Cash refunds from income taxes	4	9
Cash paid for interest	5,723	190
Cash paid for amounts included in the measurement of operating lease liabilities	2,127	4,533
Operating lease assets obtained in exchange for operating lease liabilities	585
Accrued purchases of equipment and improvements	$ 20	$ 144